Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.